Weekly Recap | TMO.US +0.49%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 07:57 AMTMO+0.13%
Weekly Recap | Heamonetics +13.38%, CSL Plasma rollout fuels the rallyWeekly Review·Oct 10, 2026 at 06:43 AMHAE+2.01%
Weekly Recap | HeartBeam +10.49%, FDA breakthrough status sparks spike then fadeWeekly Review·Oct 10, 2026 at 06:16 AMBEAT-11.29%